Covid-19 News

  • Doctors Warn: Two Completely Separate Bouts of COVID-19 Infection Possible


    https://scitechdaily.com/docto…id-19-infection-possible/


    It may be possible to have two completely separate bouts of COVID-19, doctors have warned in the journal BMJ Case Reports after treating a man whose infections were separated by 4 months of no symptoms and serial negative tests for the virus.


    Waning immunity might heighten the risk of reinfection, but severe infection first time around may be followed by milder symptoms second time around, they suggest.


    It’s not unknown for people to become reinfected with SARS-CoV-2, the virus responsible for COVID-19 infection, but very few cases have been reported. And it’s not yet clear if this actually represents persistent viral shedding rather than genuine reinfection.


    In a bid to shed some light on this, the authors report a case of a man in his 40s who was admitted to hospital with mild COVID-19 infection 4 months after an initial bout of severe disease in April 2020.


    The man had well-controlled type 2 diabetes, an underactive thyroid gland, and he was obese — known risk factors for severe COVID-19 infection.


    First time around, he was admitted to hospital with breathing difficulties and a high-pitched wheeze caused by disrupted airflow, known as stridor.


    He developed respiratory failure, and required mechanical ventilation and blood thinners as well as various other drugs used to treat COVID-19.


    He was in hospital for 2 months and developed serious complications, including a hospital acquired infection (MRSA), gastrointestinal bleeding, ventilator-associated pneumonia and kidney failure. When he stabilized, he was subsequently discharged to an acute care facility for rehabilitation.


    Second time around in August 2020, he tested positive for SARS-CoV-2, after four interval negative tests during the preceding three months. He stayed in hospital for just 1 day.


    Two weeks later he was admitted to hospital with shortness of breath; he told doctors that he had had intermittent episodes of choking, shortness of breath, and stridor. This third hospital stay lasted a week.


    Once again, he tested positive for SARS-CoV-2, insisting that he had had very little exposure to other people, except for relatives and his immediate family who had no symptoms and had not been ill recently.

  • Fluid dynamics of COVID-19 airborne infection suggests urgent data for a scientific design of social distancing


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen


    Infection by COVID-19 is largely caused by airborne transmission, a phenomenon that has rapidly attracted a great deal of attention from the scientific community. The SARS-CoV-2 virus hosted in different tracts of the respiratory system is emitted as we breathe, speak or sing or through more violent expulsions like coughing or sneezing. In these common actions, people emit thousands or even millions of small droplets of saliva acting as a vector for the virus. Given that the disease travels on respiratory droplets, social distancing is of paramount importance to limit the spread. Indeed, droplets are heavier than air, and sooner or later, they fall to the ground, which will tame their infectious potential.

  • Cheap Gout Drug Help Cuts Need for Oxygen Therapy and Hospital Stay in COVID-19 Patients


    https://scitechdaily.com/cheap…tay-in-covid-19-patients/


    Colchicine worth adding to standard treatment for moderate to severe infection, says researchers.


    Colchicine, a cheap drug normally used to treat gout, helps to cut the need for oxygen therapy and hospital stay in COVID-19 patients, reveal the results of a small clinical trial, published in the online journal RMD Open.


    The findings prompt the Brazilian researchers to suggest that although it’s not possible to confirm whether colchicine can alter the risk of death, it may nevertheless be worth adding it to standard treatment for hospital patients with moderate to severe COVID-19 infection.


    Colchicine has been successfully used to treat and prevent systemic inflammatory conditions, including gout; systemic inflammation is a cardinal feature of moderate to severe COVID-19 infection.


    The researchers therefore wanted to find out if adding it to standard treatment might reduce the need for supplemental oxygen, length of hospital stay, including in intensive care, and risk of death in patients with moderate to severe COVID-19 infection.


    Moderate disease was defined as fever, breathing difficulties, and pneumonia; severe disease was defined as all of the above, plus a rapid breathing rate of 30 or more times a minute and low levels of oxygen in the body (oxygen saturation of 92% or less).


    Between April and August 2020, they randomly assigned 75 patients admitted to hospital with moderate to severe COVID-19 infection to receive either standard treatment plus 0.5 mg colchicine three times a day for 5 days, followed by the same dose twice a day for 5 days, or standard treatment plus a dummy (placebo) drug.


    Standard treatment comprised doses of the antibiotic azithromycin, the antimalarial hydroxychloroquine, and the blood thinner heparin, plus a steroid (methylprednisolone) if the need for supplemental oxygen was considerable — equal to 6 liters/minute or more — and intensive care required.

  • Life-threatening fungal infection reported in several COVID-19 patients in India


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen


    Doctors are reporting a rise in cases of a rare black fungal infection, called Mucormycosis, among COVID-19 patients in India. The life-threatening infection often occurs in people with weak immune systems, such as severe diabetes. It can be fatal if left untreated.


    Though there presently exists no study linking COVID-19 to mucormycosis, many doctors have observed that recent mucormycosis cases coming for treatment are those who recently recovered from COVID-19 and who have high blood sugar levels. The number of such cases have also sharply risen, they say. However, mucormycosis is not contagious, that is it does not spread from person to person.


    What is mucormycosis?

    The infection is caused by mucormyete molds, an organism present in the air, in leaves, piles of compost, soil and rotting wood. When exposed, the fungus can infect your central nervous system, eyes, sinuses, lungs, etc. But not everyone exposed to the fungus catches the infection.


    Early symptoms of the infection include obstruction in the nose, swelling in the eye or cheeks, and black dry crusts in the nose, smelly black nasal discharge, face numbness, fever, cold, etc. If neglected, it can even spread to the eyes and then the brain, making it fatal. If it entered the body via a cut or bruise in the skin, it could show up as blackened skin tissue.


    Typically, the infection overtakes the host when the latter is immunocompromised. That is why it is reported in persons with uncontrolled diabetes mellitus, HIV and cancer patients, those who had organ transplant, etc. Prior to COVID-19, most mucormycosis cases were reported in those with these conditions. The United States’ Centers for Disease Control and Prevention (CDC) estimated a yearly rate of 1.7 mucormycosis cases per 1 million population. The CDC also reported a mortality rate of 54% of mucormycosis cases.


    However, since the pandemic, persons who have recovered from COVID-19 too have been contracting the disease. In fact, the Gujarat Health Department had in December issued an advisory to doctors and officials over the recent spurt of cases among COVID-19 patients.


    Many of these cases are mucormycosis of the maxilla or upper jaw, which leads to the entire jaw detaching from the skull.

  • Sounds like AIDS to me, so why don't we look if the immune dysregulation has triggered HIV or XMRV retroviruses.

    I know why? Because at scale the entire internet is policed and no media company in the world would talk about this. Even small outposts like this are targeted.


    Which is why, dear admins, character assignation is the easiest tactic to stop conversation, but stopping conversation is your own enslavement (imagine having a brutal post Covid disease and not being allowed to know what the hell it is!). "They" (Churchill, Obama, Bush, Merkel) make that V symbol for a snake who is lurking under the sand.

  • Q: So you think the epidemic started because Xi did not receive the real information?

    At the beginning he did not get the real news, but he said in a meeting on 7 January that the situation was under his personal command.

    The virus was in Italy August 2019.... What the hell are they doing in Wuhan? Ask Fauci and his friends when they planted it? Check the New York cases of April 2019 (in CDC record)!

    Last week, British Prime Minister Boris Johnson said preliminary data from several research groups suggested that B.1.1.7, which was first identified in the United Kingdom, was spreading more quickly than previous variants and was also associated with a higher risk of death.

    The death rate in Germany is ultra high today because a simple - dilettante lock-down is the perfect method to kill people. If you add that the B1.171 virus does obviously produce more and stickier particles, people staying home simply get even higher dose than before.

    My personal experience with severe CoV-19 cases clearly shows that people staying home, getting it from the partner are at 10-100x risk to die.

    So if you go out without an FP98 mask (as I do it today again in a crowded shop) then please buy a HEPA filter room air cleaner for the others staying home. They will get sick too but as mild as you.

  • Risk of dying from new COVID variant Scientists have released the data behind UK Prime Minister Boris Johnson’s warning last week that the new COVID-19 variant B.1.1.7 is linked to more deaths. The chance of dying is around 35% higher for people who are confirmed to be infected with the new variant. The risk is most pronounced for older men. The chance of death for an 85-year-old man increases from about 17% to nearly 22% for those confirmed to be infected with the variant. Researchers caution that the data are preliminary, and it is not clear whether the variant is deadlier than previous strains or is spreading to more people who are vulnerable to severe disease.Nature | 4 min read Reference: medRxiv paper

    https://www.medrxiv.org/conten…101/2021.02.01.21250959v1

  • DR Lauring and Coronavirus Variants.


    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • New Israeli drug cured 29 of 30 moderate/serious COVID cases in days — hospital


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen



    A new coronavirus treatment being developed at Tel Aviv’s Ichilov Medical Center has successfully completed phase 1 trials and appears to have helped numerous moderate-to-serious cases of COVID-19 quickly recover from the disease, the hospital said Friday.


    Hailing a “huge breakthrough,” the hospital said Prof. Nadir Arber’s EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse, and all 30 recovered — 29 of them within three to five days.

    The medicine fights the cytokine storm — a potentially lethal immune overreaction to the coronavirus infection that is believed to be responsible for much of the deaths associated with the disease.


    It uses exosomes — tiny carrier sacs that shuttle materials between cells — to deliver a protein called CD24 to the lungs, which Arber has spent decades researching.

    This protein is located on the surface of cells and has a well known and important role in regulating the immune system,” said researcher Shiran Shapira of Arber’s lab.


    The protein helps calm down the immune system and curb the storm.

    The preparation is inhaled once a day for a few minutes, for five days,” Arber said. “The preparation is directed straight to the heart of the storm — the lungs — so unlike other formulas… which selectively restrain a certain cytokine, or operate widely but cause many serious side effects, EXO-CD24 is administered locally, works broadly and without side effects.”


    The medicine will now move on to further trial phases, but hospital officials were already hailing it as a possible game-changer in fighting serious COVID-19 illness.

  • A Moral Catastrophe”: Africa CDC Head Says Lack of Vaccines for the Continent Will Imperil World


    https://www.democracynow.org/2…ong_africa_covid_vaccines


    Countries across the African continent are facing a second COVID-19 outbreak, linked to a variant first found in South Africa that has been detected in Botswana, Ghana, Kenya, Comoros and Zambia and more than 20 non-African countries so far. There is concern new variants, which scientists believe are more infectious, could spread the virus further before widespread vaccination begins. More than 40 African countries have been hit by this second wave, and just six have received relatively small shipments of vaccines. John Nkengasong, director of the Africa Centers for Disease Control and Prevention, says the world faces “a moral catastrophe” without vaccine equity. “It has to be very clear that no part of the world will be safe until all parts of the world are safe,” he says. “We either come out of this together or we go down together. There’s no middle ground in this.”

  • After receiving Chinese vaccine as gift, Pakistan says drug not effective for elderly


    https://www.wionews.com/south-…ve-for-elderly-361536/amp


    After receiving half a million Sinopharm coronavirus vaccine doses as a gift from China, Pakistan on Thursday said that the shots are not effective for people over 60 years of age.


    After conducting preliminary analysis by an expert committee, the vaccine has been recommended only for people aged 18-60 years, Faisal Sultan, Special Assistant to the Prime Minister on Health said.

  • Hailing a “huge breakthrough,” the hospital said Prof. Nadir Arber’s EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse, and all 30 recovered — 29 of them within three to five days.

    Whether this is enough to suppress long lasting problems due to endothelium damage in hart, kidney, brain etc. we don't yet know. But usually at least 1 out of 100 cases is delivered far to late to a hospital where such drugs can be a big help. So this will help to save the remaining 0.5% that missed an early enough ivermectin treatment.
    But what I heard from many such late cases is: Even if they survive, the lung damage at delivery time is irreversible. So the rest of their live happens in an intense care home.

    Let's hope it's one more sword in the fight! Israel will certainly need it as the RSA variant will soon "eat through" the population again.


    A Moral Catastrophe”: Africa CDC Head Says Lack of Vaccines for the Continent Will Imperil World

    Sorry to say: Africa is not affected by CoV-19. The death rate is 10-20 x lower than in western states. Exceptions are as usual the Western like states as RSA & Tunesia.


    Such public statements usually by bribed CDC place holders have only one goal: Generate money for big pharma.

  • Fear that Chinese citizen journalist Zhang Zhan could be "tortured in prison" for reporting on COVID


    https://www.cbsnews.com/amp/ne…han-hunger-strike-prison/


    Beijing — Citizen journalist Zhang Zhan, a 37-year-old former lawyer, has given up hope of avoiding her four-year prison sentence for reporting on the coronavirus outbreak in the Chinese city of Wuhan early last year. A year after Zhang arrived in Wuhan, risking both arrest and her own health to tell people what was happening in the city believed by many to be ground zero of the pandemic, her lawyer told CBS News "the case is closed," and she's not looking at any further legal options.

    Authorities have ordered Zhang Keke not to speak to the press and censored him on social media. He said his career and even his family have been threatened, but he was determined to continue speaking up for his client, so he agreed to talk to CBS News.


    "If lawyers do nothing, what will this society turn into?" he told CBS News.


    Zhang Zhan's treatment has drawn international condemnation. The United States, the United Nations human rights office and the European Union all denounced China's court system for sentencing Zhang to prison in December.


    "The United States strongly condemns the People's Republic of China's (PRC) sham prosecution and conviction of citizen journalist Zhang Zhan on December 28. We call on the PRC government to release her immediately and unconditionally," then-Secretary of State Mike Pompeo said in a statement. "The Chinese Communist Party (CCP) has shown once again it will do whatever it takes to silence those who question the Party's official line, even regarding crucial public health information."

  • Coronavirus Model Predicts U.S. Death Toll to Top 630,000 by June


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen


    If the estimate from the University of Washington's Institute for Health Metrics and Evaluation plays out, it would mean the U.S. will add about 175,000 more fatalities over the next roughly 120 days.


    But the researchers behind the model raised alarm over recent data that indicated the variant first found in South Africa infected participants who had prior COVID-19 infections.

    They said that the finding could mean that "herd immunity is only variant-specific," and if the data is confirmed in other vaccines, it would mean the model's "worse scenario is likely too optimistic," researchers wrote in a brief.

    The model's worst case scenario, which assumes vaccinated people will resume travel as normal, predicts over 700,000 total deaths by the start of June. Travel returning to near normal among the vaccinated could drive daily deaths to increase in April and May across the following 16 states and Washington, D.C.: Arizona, California, Connecticut, Delaware, Florida, Hawaii, Maine, Massachusetts, New Mexico, New York, North Carolina, Oregon, Rhode Island, Vermont, Virginia and West Virginia.


    "The best strategies to manage this period of the pandemic are rapid scale-up of vaccination, continued and expanded mask-wearing, and concerted efforts to avoid rebound mobility in the vaccinated," the researchers wrote.

  • Pfizer vaccine only about 30% effective ?


    https://www.infosperber.ch/ges…irksam-keine-transparenz/


    One more English link: https://blogs.bmj.com/bmj/2021…details-and-the-raw-data/

    What Pfizer did not tell the public and FDA only delivered in a report at the end of the drawer.


    A well known Swiss specialist for vaccine certification analyzed the details.


    In the report we find 3410 additional sick individuals that add to the known ones. These were no counted because the PCR test (how many cycles???) did not show a positive signal. Problem: This happens for 10 ..20% of all people delivered to a hospital.


    So Pfizer did no secondary tests at all, what would have been mandatory for these cases.


    Thus Pfizer's 95% are blatantly wrong anything between 30..80% is real but not 95%

    This does not mean that the vaccination does not work by preventing severe cases. It only tells its not a vaccine in the sense that it fully protects you.

  • You did not say "mafia" one time. Are you feeling okay?

  • One more English link: https://blogs.bmj.com/bmj/2021…details-and-the-raw-data/

    What Pfizer did not tell the public and FDA only delivered in a report at the end of the drawer.

    Its good to see that at least one leading journal...BMJ

    has people who don't trust BigPharma, whether they bear gifts of Sicilian.Arancini, American Pie or Stroganoff

    https://www.bmj.com/about-bmj/editorial-staff/peter-doshi

    " an assistant professor of pharmaceutical health services research at the University of Maryland School of Pharmacy. His research focuses on policies related to drug safety and effectiveness evaluation in the context of regulation, evidence-based medicine, and debates over access to data. Doshi also has strong interests in journalism as a vehicle for encouraging better practice and improving the research enterprise.

    "

    We need the raw data

    Addressing the many open questions about these trials requires access to the raw trial data.

    But no company seems to have shared data with any third party at this point.

    Pfizer says it is making data available “upon request, and subject to review.” This stops far short of making data publicly available, but at least leaves the door open

    . How open is unclear, since the study protocol says Pfizer will only

    start making data available 24 months after study completion.

    Moderna’s data sharing statement states data “may be available upon request once the trial is complete.” This translates to sometime in mid-to-late 2022, as follow-up is planned for 2 years.

    Things may be no different for the Oxford/AstraZeneca vaccine which has pledged patient-level data “when the trial is complete.”

    and the ClinicalTrials.gov entry for the Russian Sputnik V vaccine says there are no plans to share individual participant data.


    "

    The trust we place in licensed medicines is a strong reason for insisting on full data transparency and reporting, even in the face of a pandemic. Few would disagree with the importance of data transparency, but even during normal times it remains a challenge—so, why demand it during a pandemic? The reason is that data transparency builds the foundation for information we can trust. Data secrecy, by contrast, creates risks too large to take.

    The first critical risk is that of an exaggerated estimate of a product’s benefits when relying on scientific publications alone, not the underlying data. When the underlying clinical study reports for oseltamivir {TAmifLU}}were finally made public they revealed that the data collection on lower respiratory tract complications relied on patients’ self-reporting, which makes sense for some outcome measures, such as pain, but not pneumonia. The result was a complete loss of confidence in the quality of data collected for the key performance assumption underpinning global stockpiling.12

    The second critical risk is underestimating a product’s side effects. A year after novel vaccines were manufactured and rolled out on expedited timelines to tackle the threat of 2009 H1N1 swine flu, post-marketing reports of narcolepsy emerged in some Pandemrix vaccine recipients. But it would take a further seven years—and a lawsuit—to unearth internal pharmacovigilance reports by the manufacturer, which had suggested that problems with the vaccine’s safety had actually been produced in real time during the pandemic.13

    Copious evidence already shows that adverse event data collected in trials are under-reported in journal publications.14 Moreover, serious adverse events may disappear if classified under rubrics such as “intercurrent illness” or “new medical histories,” which do not require serious adverse event reports—as has happened in vaccine and treatment trials.1516

    Only publicly available full datasets will allow for a thorough assessment of side effects.

  • Climate change "may have played a key role" in coronavirus pandemic, study says


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen


    Human-caused climate change "may have played a key role" in the coronavirus pandemic. That's the conclusion of a new study which examined how changes in climate have transformed the forests of Southeast Asia, resulting in an explosion of bat species in the region.


    The researchers found that, due to changes in vegetation over the past 100 years, an additional 40 species of bat have moved into the region, carrying with them 100 more types of bat-borne coronaviruses. Bats are known carriers of coronaviruses, with various species carrying thousands of different types. Many scientists believe the virus that started the worldwide COVID-19 pandemic originated in bats in southern China's Yunnan province or neighboring areas before it crossed paths with humans.